AstraZeneca has changed the name of its coronavirus vaccine in the midst of a wave of discredit due to possible adverse effects related to it. After requesting permission from the European Medicines Agency (EMA), it has given the go-ahead for the antigen to be renamed Vaxzevria.
The cases of thrombosis detected in some people who received this antiviral caused a stoppage of injections with the pharmaceutical compound in Europe. After assessing the situation, the EMA ruled that the vaccine was .
The name change would be a business strategy to overcome the one generated by the cases of thrombosis with thrombocytopenia that have been registered in patients from several countries after receiving the dose.
Little by little – Vaxzevria from now on – and even in some cases such as that of Spain, the ages of the patients to whom it will be administered have been modified upwards, who may be up to 65 years old.
Facebook Comments
Disqus